Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1995 1
1996 6
1997 6
1998 9
1999 10
2000 6
2001 6
2002 16
2003 11
2004 18
2005 21
2006 17
2007 21
2008 23
2009 29
2010 32
2011 37
2012 26
2013 37
2014 48
2015 39
2016 32
2017 28
2018 22
2019 17
2020 24
2021 32
2022 17
2023 9
2024 11
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

537 results

Results by year

Filters applied: . Clear all
Page 1
The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study.
Roehrborn CG, Siami P, Barkin J, Damião R, Major-Walker K, Nandy I, Morrill BB, Gagnier RP, Montorsi F; CombAT Study Group. Roehrborn CG, et al. Eur Urol. 2010 Jan;57(1):123-31. doi: 10.1016/j.eururo.2009.09.035. Epub 2009 Sep 19. Eur Urol. 2010. PMID: 19825505 Clinical Trial.
INTERVENTION: Oral daily tamsulosin, 0.4 mg; dutasteride, 0.5 mg; or a combination of both. MEASUREMENTS: The 4-yr primary end point was time to first AUR or BPH-related surgery. ...RESULTS AND LIMITATIONS: Combination therapy was significantly superior to tamsulosin …
INTERVENTION: Oral daily tamsulosin, 0.4 mg; dutasteride, 0.5 mg; or a combination of both. MEASUREMENTS: The 4-yr primary end point …
Pumpkin seed oil (Cucurbita pepo) versus tamsulosin for benign prostatic hyperplasia symptom relief: a single-blind randomized clinical trial.
Zerafatjou N, Amirzargar M, Biglarkhani M, Shobeirian F, Zoghi G. Zerafatjou N, et al. BMC Urol. 2021 Oct 19;21(1):147. doi: 10.1186/s12894-021-00910-8. BMC Urol. 2021. PMID: 34666728 Free PMC article. Clinical Trial.
Patients were randomized into two groups. One group received 0.4 mg tamsulosin every night at bedtime and the other received 360 mg pumpkin seed oil twice a day. ...None of the patients in the pumpkin group experienced drug side effects, while dizziness (5.9%), headache (2 …
Patients were randomized into two groups. One group received 0.4 mg tamsulosin every night at bedtime and the other received 360 mg p …
Tamsulosin and Time to Spontaneous Void After Hysterectomy: A Randomized Controlled Trial.
Gabra M, Hall C, McCann L, Shah J, Jones I, Masjedi A, Runke S, Hsu CH, Aguirre A. Gabra M, et al. Obstet Gynecol. 2024 Dec 1;144(6):810-816. doi: 10.1097/AOG.0000000000005724. Epub 2024 Sep 12. Obstet Gynecol. 2024. PMID: 39265173 Clinical Trial.
METHODS: This single-center, block-randomized, placebo-controlled, double-blind superiority trial evaluated the effect of 0.4 mg tamsulosin compared with placebo on the time to void after hysterectomy. Patients who underwent outpatient minimally invasive hysterectomy were …
METHODS: This single-center, block-randomized, placebo-controlled, double-blind superiority trial evaluated the effect of 0.4 mg tamsulos …
Comparative study between Tamsulosin, Silodosin and Tadalafil as a medical expulsive therapy for lower ureteral stones.
Abdelaal MA, El-Dydamony EM. Abdelaal MA, et al. Arch Ital Urol Androl. 2023 Feb 22;95(1):10849. doi: 10.4081/aiua.2023.10849. Arch Ital Urol Androl. 2023. PMID: 36924384 Free article. Clinical Trial.
OBJECTIVE: To compare the efficacy of Tamsulosin, Silodosin and Tadalafil as a medical expulsive therapy for treatment of distal ureteral calculi. ...Patients were randomly divided into three groups. Patients in group A received Tamsulosin 0.4mg, in group B received …
OBJECTIVE: To compare the efficacy of Tamsulosin, Silodosin and Tadalafil as a medical expulsive therapy for treatment of distal uret …
Anti-osteoporotic drugs affect the pathogenesis of gut microbiota and its metabolites: a clinical study.
Zhang RK, Yan K, Chen HF, Zhang Y, Li GJ, Chen XG, Ge LP, Cheng F, Chen ZN, Yao XM. Zhang RK, et al. Front Cell Infect Microbiol. 2023 Jul 4;13:1091083. doi: 10.3389/fcimb.2023.1091083. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37475958 Free PMC article. Clinical Trial.
The metabolites for which major changes were observed were capsazepine, Phe-Tyr, dichlorprop, D-pyroglutamic acid and tamsulosin. These metabolites may act through metabolic pathways, the citrate cycle (TCA cycle) and beta alanine metabolism. Combined analysis showed that …
The metabolites for which major changes were observed were capsazepine, Phe-Tyr, dichlorprop, D-pyroglutamic acid and tamsulosin. The …
Distal Ureteric Stones and Tamsulosin: A Double-Blind, Placebo-Controlled, Randomized, Multicenter Trial.
Furyk JS, Chu K, Banks C, Greenslade J, Keijzers G, Thom O, Torpie T, Dux C, Narula R. Furyk JS, et al. Ann Emerg Med. 2016 Jan;67(1):86-95.e2. doi: 10.1016/j.annemergmed.2015.06.001. Epub 2015 Jul 17. Ann Emerg Med. 2016. PMID: 26194935 Free article. Clinical Trial.
The median stone size was 4.0 mm in the tamsulosin group and 3.7 mm in the placebo group. Of 316 patients who received CT at 28 days, stone passage occurred in 140 of 161 (87.0%) in the tamsulosin group and 127 of 155 (81.9%) with placebo, a difference of 5.0% (95% …
The median stone size was 4.0 mm in the tamsulosin group and 3.7 mm in the placebo group. Of 316 patients who received CT at 28 days, …
Clinical efficacy evaluation and prevention of adverse reactions in a randomized trial of a combination of three drugs in the treatment of cancerous pudendal neuralgia.
Hou J, Lin Y, Fang Y, Li X, Li XN, Yang Y, Liu N, Jiang X, Yu Y, Zhou Y, Mi X, Ni Z, Lu X, Jin NY. Hou J, et al. Ann Palliat Med. 2021 May;10(5):5754-5762. doi: 10.21037/apm-21-590. Epub 2021 May 6. Ann Palliat Med. 2021. PMID: 33977736 Free article. Clinical Trial.
Co-occurring in both groups during treatment, 10 participants with urinary dysfunction were treated with tamsulosin hydrochloride sustained-release capsules, no urinary retention occurred, catheterization was avoided, tamsulosin hydrochloride sustained-release capsu …
Co-occurring in both groups during treatment, 10 participants with urinary dysfunction were treated with tamsulosin hydrochloride sus …
Tamsulosin and placebo vs tamsulosin and tadalafil in male lower urinary tract symptoms: a double-blinded, randomised controlled trial.
Nagasubramanian S, John NT, Antonisamy B, Mukha RP, Jeyachandra Berry CS, Kumar S, Devasia A, Kekre NS. Nagasubramanian S, et al. BJU Int. 2020 May;125(5):718-724. doi: 10.1111/bju.15027. Epub 2020 Feb 27. BJU Int. 2020. PMID: 32012409 Clinical Trial.
OBJECTIVE: To compare the efficacy and safety of tamsulosin vs the combination of tamsulosin and tadalafil in male lower urinary tract symptoms (LUTS). ...Men aged >45 years with moderate LUTS and a maximum urinary flow rate (Q(max) ) of 5-15 mL/s were included. …
OBJECTIVE: To compare the efficacy and safety of tamsulosin vs the combination of tamsulosin and tadalafil in male lower urina …
A Comparison of Boron Supplement and Tamsulosin as Medical Expulsive Therapy for Urinary Stones After Extracorporeal Shock Wave Lithotripsy: a Randomized Controlled Clinical Trial.
Jalali S, Borumandnia N, Basiri A, Nagiee M, Amiri FB, Tavasoli S, Kheirolahkhani Y, Taheri M. Jalali S, et al. Biol Trace Elem Res. 2023 Nov;201(11):5126-5133. doi: 10.1007/s12011-023-03597-0. Epub 2023 Feb 21. Biol Trace Elem Res. 2023. PMID: 36808295 Clinical Trial.
We aimed to compare the effectiveness of boron supplement (due to its anti-inflammatory effect) and tamsulosin in the passage of stone fragments after ESWL. Eligible patients after ESWL were randomly assigned to two groups and were treated with boron supplement (10 mg/BD) …
We aimed to compare the effectiveness of boron supplement (due to its anti-inflammatory effect) and tamsulosin in the passage of ston …
Combination therapy with tamsulosin and traditional herbal medicine for lower urinary tract symptoms due to benign prostatic hyperplasia: A double-blinded, randomized, pilot clinical trial.
Lee CL, Shin HK, Lee JY, Kwon O, Seo CS, Kim AR, Seo BN, Yang SW, Song KH, Lim JS, Park JM, Na YG, Shin JH. Lee CL, et al. Int J Urol. 2022 Jun;29(6):503-509. doi: 10.1111/iju.14821. Epub 2022 Mar 16. Int J Urol. 2022. PMID: 35297106 Free PMC article. Clinical Trial.
OBJECTIVES: To evaluate the efficacy and safety of tamsulosin and Hachimijiogan or Ryutanshakanto in patients with lower urinary tract symptoms due to benign prostatic hyperplasia. ...Only the pain sub-score of the National Institutes of Health-Chronic Prostatitis Symptom …
OBJECTIVES: To evaluate the efficacy and safety of tamsulosin and Hachimijiogan or Ryutanshakanto in patients with lower urinary trac …
537 results